Actavis Elizabeth, L.L.C. v. Mensing

Consolidated with:

Docket No.
Op. Below
Argument
Mar 30, 2011
Tr.
Opinion
Vote
5-4
Author
Thomas
Term

Holding: Federal drug regulations applicable to generic drug manufacturers directly conflict with, and thus preempt, state-law tort claims alleging a failure to provide adequate warning labels.

Judgment: Reversed, 5-4, in an opinion by Justice Clarence Thomas on June 23, 2011. The Chief Justice and Justices Scalia and Alito joined the opinion in full, while Justice Kennedy joined as to all but Part III-B-2. Justice Sotomayor filed a dissenting opinion, which was joined by Justices Ginsburg, Breyer, and Kagan.

SCOTUSblog Coverage

Briefs and Documents

CLICK HERE FOR FULL VERSION OF THIS STORY

Merits Briefs

Amicus Briefs

[##CERT-STAGE##]

CLICK HERE FOR FULL VERSION OF THIS STORY